Moving diagnostic frontiers in dermatology

At Dermagnostix, we are redefining the future of molecular diagnostics in dermatology. Our mission is to deliver innovative, scalable, and point-of-need diagnostic solutions for dermatologists, diagnostic laboratories, and academic as well as pharmaceutical research institutions. With our quick, precise, and fully automated tests, we empower skin experts to achieve objective diagnostic clarity and recommend the most effective treatment for improved skin health. Our focus: precision, speed, and usability – Made in Germany.

Contact us

Company history

Dermagnostix was founded as a spin-off from the Hahn-Schickard Institute in Freiburg, the Helmholtz Zentrum München (HMGU), and TU Munich. Built on decades of world-class research in dermatology, immunology, bioinformatics, and microfluidics, our company combines scientific excellence with practical application. Today, we are headquartered in Freiburg, Southern Germany, a region known for innovation in medical technology.

While modern therapies for inflammatory skin diseases and skin cancer have advanced rapidly, diagnostics have lagged behind. Dermagnostix closes this gap by bringing objective molecular results directly into dermatology practices and laboratories.

 

Strategic Growth & Lumalytix

In 2025, Dermagnostix expanded its portfolio with the launch of the sub-brand Lumalytix. As part of this strategic move, the company took over the DiskReader business and the underlying fluorescence detector technology, securing full in-house production of the Analyzer. By internalizing the development and manufacturing of critical optical components, Dermagnostix strengthened its technological independence, ensured long-term scalability, and established rigorous quality control. This allows the company to continuously advance key technologies while meeting the growing demand in molecular diagnostics, research, and industrial applications. Among the established products are the FluoSens Go and FluoSens Integrated modules, widely recognized for their compact design, high sensitivity, and broad dynamic range. With Lumalytix, Dermagnostix positions itself as a leading provider of fluorescence detection and innovative diagnostic solutions – proudly developed and manufactured in Germany.

Management

Prof. Natalie Garzorz-Stark, MD, PhD, MHBA

Chief Executive Officer, Co-Founder, Managing Director

Ludwig Gutzweiler

Chief Technology Officer, Managing Director

Sören Spitzer

Chief Financial Officer

Prof. Helmut Laaff, MD

Chief Strategy Officer

Sreejith Vasudevan

Head of International Commercialization

Melanie Schäpers

Head of Operations

Martin Meyer

Head of Quality Management and Regulatory Affairs

Made in Germany

Dermagnostix - a spin-off company of

Awards

2025

2024

2022

2022

2021

2020

2020

2020

2020

2020

2020

2019

2018

Member of

Certificates

Certificate

Since November 2022 Dermagnostix is officially EN ISO 13485 certified.

View certificate

Support programme INVEST

Dermagnostix was granted a notice of eligibility by BAFA as part of the INVEST funding measure of the Federal Ministry of Economics and Climate Protection to subsidize venture capital from private investors for young innovative companies.

Learn More